HAI2; Kop; PB; Placental Bikunin; Hepatocyte growth factor activator inhibitor type 2
CYP19A1; CYPXIX; ARO; ARO1; CPV1; CYAR; CYP19; P450AROM; P450-AROM; Estrogen synthase; Cytochrome P450,Family 19,Subfamily A,Polypeptide 1
3-Oxo-5 Alpha-Steroid Delta 4-Dehydrogenase Alpha 1
ABC-C13; PRED6; C21orf73; Putative ATP-binding cassette sub-family C member 13
RIPK5; Dusty PK; RIP5; SgK496; Receptor Interacting Protein Kinase 5; RIP-homologous kinase; Sugen kinase 496; Receptor-interacting serine/threonine-protein kinase 5
CHR-NA3; CHRN-A3; N-AChRA3; NAChRA3; N-AChR-A3; Neuronal Acetylcholine Receptor Alpha 3
PAG1; Pregnancy associated glycoprotein 1
Apo-A2; Apolipoprotein A-II; ProapoA-II; Truncated apolipoprotein A-II
ACS4; FACL4; LACS4; MRX63; MRX68; Fatty-Acid-Coenzyme A Ligase,Long-Chain 4; Mental Retardation,X-Linked 63; Lignoceroyl-CoA Synthase
P1NP; N-Propeptide Of Type I Procollagen; Procollagen I Amino Terminal Propeptide; PINP; Procollagen I N-Terminal Propeptide